Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Opioid K receptor variant is associated with a delayed onset of dyskinesias in Parkinson's disease.

Cilia R, Asselta R, Cereda E, Benfante R, Barbella G, Vallauri D, Marabini L, Fornasari D, Goldwurm S, Pezzoli G.

J Neurol Neurosurg Psychiatry. 2017 Jul 19. pii: jnnp-2017-316235. doi: 10.1136/jnnp-2017-316235. [Epub ahead of print] No abstract available.

PMID:
28724719
2.

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

Cilia R, Laguna J, Cassani E, Cereda E, Pozzi NG, Isaias IU, Contin M, Barichella M, Pezzoli G.

Neurology. 2017 Aug 1;89(5):432-438. doi: 10.1212/WNL.0000000000004175. Epub 2017 Jul 5.

PMID:
28679598
3.

Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.

Cereda E, Cilia R, Canesi M, Tesei S, Mariani CB, Zecchinelli AL, Pezzoli G.

J Neurol. 2017 Jun;264(6):1254-1263. doi: 10.1007/s00415-017-8523-y. Epub 2017 May 26.

PMID:
28550482
4.

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JÁ, Cilia R, Ballanger B, Niethammer M, Stoessl JA; IPMDS-Neuroimaging Study Group.

Mov Disord. 2017 Feb;32(2):181-192. doi: 10.1002/mds.26907. Epub 2017 Feb 2. Review.

PMID:
28150432
5.

Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.

Nigro S, Arabia G, Antonini A, Weis L, Marcante A, Tessitore A, Cirillo M, Tedeschi G, Zanigni S, Calandra-Buonaura G, Tonon C, Pezzoli G, Cilia R, Zappia M, Nicoletti A, Cicero CE, Tinazzi M, Tocco P, Cardobi N, Quattrone A.

Eur Radiol. 2017 Jun;27(6):2665-2675. doi: 10.1007/s00330-016-4622-x. Epub 2016 Oct 19.

PMID:
27761709
6.

Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.

Cilia R, Tunesi S, Marotta G, Cereda E, Siri C, Tesei S, Zecchinelli AL, Canesi M, Mariani CB, Meucci N, Sacilotto G, Zini M, Barichella M, Magnani C, Duga S, Asselta R, Soldà G, Seresini A, Seia M, Pezzoli G, Goldwurm S.

Ann Neurol. 2016 Nov;80(5):662-673. doi: 10.1002/ana.24777. Epub 2016 Oct 3.

PMID:
27632223
7.

Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson's disease.

Cilia R, Benfante R, Asselta R, Marabini L, Cereda E, Siri C, Pezzoli G, Goldwurm S, Fornasari D.

Parkinsonism Relat Disord. 2016 Aug;29:96-103. doi: 10.1016/j.parkreldis.2016.05.017. Epub 2016 May 17.

PMID:
27237108
8.

Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile.

Cassani E, Cilia R, Laguna J, Barichella M, Contin M, Cereda E, Isaias IU, Sparvoli F, Akpalu A, Budu KO, Scarpa MT, Pezzoli G.

J Neurol Sci. 2016 Jun 15;365:175-80. doi: 10.1016/j.jns.2016.04.001. Epub 2016 Apr 16.

9.

Dementia in Parkinson's disease: Is male gender a risk factor?

Cereda E, Cilia R, Klersy C, Siri C, Pozzi B, Reali E, Colombo A, Zecchinelli AL, Mariani CB, Tesei S, Canesi M, Sacilotto G, Meucci N, Zini M, Isaias IU, Barichella M, Cassani E, Goldwurm S, Pezzoli G.

Parkinsonism Relat Disord. 2016 May;26:67-72. doi: 10.1016/j.parkreldis.2016.02.024. Epub 2016 Mar 2.

PMID:
26952697
10.

Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.

Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, Meucci N, Canesi M, Zecchinelli AL, Tesei S, Mariani CB, Sacilotto G, Zini M, Pezzoli G.

Mov Disord. 2015 Apr 15;30(5):696-704. doi: 10.1002/mds.26160. Epub 2015 Mar 11.

PMID:
25757654
11.

Swallowing disturbances in Parkinson's disease: a multivariate analysis of contributing factors.

Cereda E, Cilia R, Klersy C, Canesi M, Zecchinelli AL, Mariani CB, Tesei S, Sacilotto G, Meucci N, Zini M, Isaias IU, Cassani E, Goldwurm S, Barichella M, Pezzoli G.

Parkinsonism Relat Disord. 2014 Dec;20(12):1382-7. doi: 10.1016/j.parkreldis.2014.09.031. Epub 2014 Oct 6.

PMID:
25456827
12.

Parkinson's disease beyond 20 years.

Cilia R, Cereda E, Klersy C, Canesi M, Zecchinelli AL, Mariani CB, Tesei S, Sacilotto G, Meucci N, Zini M, Ruffmann C, Isaias IU, Goldwurm S, Pezzoli G.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):849-55. doi: 10.1136/jnnp-2014-308786. Epub 2014 Oct 3.

PMID:
25280915
13.

Glucocerebrosidase mutations in primary parkinsonism.

Asselta R, Rimoldi V, Siri C, Cilia R, Guella I, Tesei S, Soldà G, Pezzoli G, Duga S, Goldwurm S.

Parkinsonism Relat Disord. 2014 Nov;20(11):1215-20. doi: 10.1016/j.parkreldis.2014.09.003. Epub 2014 Sep 9.

14.

Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy.

Italiano D, Bianchini E, Ilardi M, Cilia R, Pezzoli G, Zanettini R, Vacca L, Stocchi F, Bramanti P, Ciurleo R, Di Lorenzo G, Polimeni G, de Luise C, Ross D, Rijnbeek P, Sturkenboom M, Trifirò G.

J Neural Transm (Vienna). 2015 Jun;122(6):799-808. doi: 10.1007/s00702-014-1314-z. Epub 2014 Sep 18.

PMID:
25230720
15.

Later age at onset in Parkinson's disease over twenty years in an Italian tertiary clinic.

Pezzoli G, Klersy C, Cilia R, Canesi M, Zecchinelli AL, Mariani CB, Tesei S, Sacilotto G, Meucci N, Zini M, Isaias IU, Ruffmann C, Barichella M, Cassani E, Goldwurm S, Cereda E.

Parkinsonism Relat Disord. 2014 Nov;20(11):1181-5. doi: 10.1016/j.parkreldis.2014.08.017. Epub 2014 Sep 3.

PMID:
25219972
16.

Novel DYT11 gene mutation in patients without dopaminergic deficit (SWEDD) screened for dystonia.

Cilia R, Reale C, Castagna A, Nasca A, Muzi-Falconi M, Barzaghi C, Marzegan A, Granata M, Marotta G, Sacilotto G, Vallauri D, Pezzoli G, Goldwurm S, Garavaglia B.

Neurology. 2014 Sep 23;83(13):1155-62. doi: 10.1212/WNL.0000000000000821. Epub 2014 Aug 22.

PMID:
25150291
17.

Impulse control disorders are associated with multiple psychiatric symptoms in Parkinson's disease.

Jaakkola E, Kaasinen V, Siri C, Martikainen K, Cilia R, Niemelä S, Joutsa J.

J Parkinsons Dis. 2014;4(3):507-15. doi: 10.3233/JPD-140351.

PMID:
25112222
18.

LRRK2-G2019S mutation is not associated with an increased cancer risk: a kin-cohort study.

Allegra R, Tunesi S, Cilia R, Pezzoli G, Goldwurm S.

Mov Disord. 2014 Sep;29(10):1325-6. doi: 10.1002/mds.25969. Epub 2014 Jul 22. No abstract available.

PMID:
25048644
19.

The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.

Cilia R, Akpalu A, Sarfo FS, Cham M, Amboni M, Cereda E, Fabbri M, Adjei P, Akassi J, Bonetti A, Pezzoli G.

Brain. 2014 Oct;137(Pt 10):2731-42. doi: 10.1093/brain/awu195. Epub 2014 Jul 17.

20.

Mutant COQ2 in multiple-system atrophy.

Sharma M, Wenning G, Krüger R; European Multiple-System Atrophy Study Group (EMSA-SG).

N Engl J Med. 2014 Jul 3;371(1):80-1. doi: 10.1056/NEJMc1311763#SA2. No abstract available.

PMID:
24988568

Supplemental Content

Loading ...
Support Center